The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Tooher, 2016, Hypertension in pregnancy and long-term cardiovascular mortality: a retrospective cohort study, Am J Obstet Gynecol, 214, 722.e1, 10.1016/j.ajog.2015.12.047
Lo, 2013, Hypertensive disease of pregnancy and maternal mortality, Curr Opin Obstet Gynecol, 25, 124, 10.1097/GCO.0b013e32835e0ef5
Lewandowski, 2014, Preeclampsia, prematurity and cardiovascular health in adult life, Early Hum Dev, 90, 725, 10.1016/j.earlhumdev.2014.08.012
Roberge, 2013, Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis, Ultrasound Obstet Gynecol, 41, 491, 10.1002/uog.12421
Bujold, 2010, Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis, Obstet Gynecol, 116, 402, 10.1097/AOG.0b013e3181e9322a
Magee, 2014, Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary, J Obstet Gynaecol Can, 36, 416, 10.1016/S1701-2163(15)30588-0
American Congress of Obstetricians and Gynecologists. Hypertension in Pregnancy. Available at: http://www.acog.org/Resources-And-Publications/Task-Force-and-Work-Group-Reports/Hypertension-in-Pregnancy. Accessed November 30, 2016.
Henderson, 2014, Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the US Preventive Services Task Force, Ann Intern Med, 160, 695, 10.7326/M13-2844
NICE Clinical Guideline. National Collaborating Center for Women’s and Children’s Health. Commissioned by the National Institute for Health and Clinical Excellence. Hypertension in pregnancy: the management of hypertensive disorders during pregnancy. Available at: http://guidance.nice.org.uk/CG107. Accessed April 17, 2014.
Caron, 2009, Low-dose ASA response using the PFA-100 in women with high-risk pregnancy, J Obstet Gynaecol Can, 31, 1022, 10.1016/S1701-2163(16)34346-8
Wojtowicz, 2011, Aspirin resistance may be associated with adverse pregnancy outcomes, Neuro Endocrinol Lett, 32, 334
Dumont, 1999, Effect of aspirin in pregnant women is dependent on increase in bleeding time, Am J Obstet Gynecol, 180, 135, 10.1016/S0002-9378(99)70163-8
Rey, 2011, Is testing for aspirin response worthwhile in high-risk pregnancy?, Eur J Obstet Gynecol Reprod Biol, 157, 38, 10.1016/j.ejogrb.2011.02.026
Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, PLoS Med, 6, e1000097, 10.1371/journal.pmed.1000097
Higgins J, Green S, eds. Cochrane handbook for systematic reviews of interventions. Cochrane Collaboration; 2011. Available at: http://handbook.cochrane.org. Accessed November 30, 2016.
Schulz, 1995, Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials, JAMA, 273, 408, 10.1001/jama.1995.03520290060030
Rey, 1996, Efficacité de l’aspirine à faible dose au cours de la grossesse en fonction des facteurs de risque maternels et foetaux, J Obstet Gynaecol Can, 18, 51
2013, Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy, Obstet Gynecol, 122, 1122
Huedo-Medina, 2006, Assessing heterogeneity in meta-analysis: Q statistic or I2 index?, Psychol Methods, 11, 193, 10.1037/1082-989X.11.2.193
Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, BMJ, 315, 629, 10.1136/bmj.315.7109.629
1994, A randomized trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group, Lancet, 343, 619, 10.1016/S0140-6736(94)92633-6
1996, Randomized trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. ECPPA (Estudo Colaborativo para Prevencao da Pre-eclampsia com Aspirina) Collaborative Group, Br J Obstet Gynaecol, 103, 39, 10.1111/j.1471-0528.1996.tb09513.x
August, 1994, 72
Ayala, 2013, Chronotherapy with low-dose aspirin for prevention of complications in pregnancy, Chronobiol Int, 30, 260, 10.3109/07420528.2012.717455
Azar R, Turpin D. Effect of antiplatelet therapy in women at high risk for pregnancy-induced hypertension. Proceedings of 7th World Congress of Hypertension in Pregnancy. Perugia (Italy); 1990:257.
Bakhti, 2011, Prevention of gravidic endothelial hypertension by aspirin treatment administered from the 8th week of gestation, Hypertens Res, 34, 1116, 10.1038/hr.2011.111
Bakhti, 2012, Prevention of gravidic endothelial hypertension by aspirin treatment administered from the 8th week of gestation, Hypertens Res, 35, 244, 10.1038/hr.2011.214
Beaufils, 1985, Prevention of pre-eclampsia by early antiplatelet therapy, Lancet, 1, 840, 10.1016/S0140-6736(85)92207-X
Benigni, 1989, Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension, N Engl J Med, 321, 357, 10.1056/NEJM198908103210604
Byaruhanga, 1998, A randomized controlled trial of low-dose aspirin in women at risk from pre-eclampsia, Int J Gynaecol Obstet, 60, 129, 10.1016/S0020-7292(97)00257-9
Caritis, 1998, Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units, N Engl J Med, 338, 701, 10.1056/NEJM199803123381101
Chiaffarino, 2004, A small randomized trial of low-dose aspirin in women at high risk of pre-eclampsia, Eur J Obstet Gynecol Reprod Biol, 112, 142, 10.1016/S0301-2115(03)00269-0
Dasari, 1998, Effect of maternal low dose aspirin on neonatal platelet function, Indian Pediatr, 35, 507
Davies, 1995, Low-dose aspirin in the prevention of hypertensive disorders of pregnancy in relatively low-risk nulliparous women, Hypertens Pregnancy, 14, 49, 10.3109/10641959509058050
Ebrashy, 2005, Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery Doppler ultrasound at 14-16 weeks pregnancy: randomized controlled clinical trial, Croat Med J, 46, 826
Ferrier C, North R, Kincaid-Smith P. Low dose aspirin delays the onset of pre-eclampsia in pregnancies with abnormal uteroplacental circulation. Proceedings of the 10th World Congress of the International Society for the Study of Hypertension in Pregnancy. Seattle (Washington); 1996:151.
Gallery, 1997, Low-dose aspirin in high-risk pregnancy, Hypertens Pregnancy, 16, 229, 10.3109/10641959709031640
Golding, 1998, A randomized trial of low dose aspirin for primiparae in pregnancy. The Jamaica Low Dose Aspirin Study Group, Br J Obstet Gynaecol, 105, 293, 10.1111/j.1471-0528.1998.tb10089.x
Grab, 2000, Effects of low-dose aspirin on uterine and fetal blood flow during pregnancy: results of a randomized, placebo-controlled, double-blind trial, Ultrasound Obstet Gynecol, 15, 19, 10.1046/j.1469-0705.2000.00009.x
Hauth, 1993, Low-dose aspirin therapy to prevent preeclampsia, Am J Obstet Gynecol, 168, 1083, 10.1016/0002-9378(93)90351-I
Hermida, 1999, Administration time-dependent effects of aspirin in women at differing risk for preeclampsia, Hypertension, 34, 1016, 10.1161/01.HYP.34.4.1016
Hermida, 1997, Time-dependent effects of low-dose aspirin administration on blood pressure in pregnant women, Hypertension, 30, 589, 10.1161/01.HYP.30.3.589
Jamal, 2012, Evaluation of the effect of metformin and aspirin on utero placental circulation of pregnant women with PCOS, Iran J Reprod Med, 10, 265
Kim, 1997, Clinical efficacy of Doppler ultrasound for low dose aspirin therapy in high risk pregnancy, Korean J Obstet Gynecol, 40, 71
McCowan, 1999, Administration of low-dose aspirin to mothers with small for gestational age fetuses and abnormal umbilical Doppler studies to increase birthweight: a randomized double-blind controlled trial, Br J Obstet Gynaecol, 106, 647, 10.1111/j.1471-0528.1999.tb08362.x
McParland, 1990, Doppler ultrasound and aspirin in recognition and prevention of pregnancy-induced hypertension, Lancet, 335, 1552, 10.1016/0140-6736(90)91377-M
Mesdaghinia, 2011, Effect of aspirin for prevention of preeclampsia in women with abnormal ultrasonic findings in uterine artery, Feyz, 15, 98
Michael, 1992, Low-dose aspirin in the prevention of pre-eclampsia: current evaluation, 183
Morris, 1996, A randomized controlled trial of aspirin in patients with abnormal uterine artery blood flow, Obstet Gynecol, 87, 74, 10.1016/0029-7844(95)00340-1
Newnham, 1995, Low dose aspirin for the treatment of fetal growth restriction: a randomized controlled trial, Aust N Z J Obstet Gynaecol, 35, 370, 10.1111/j.1479-828X.1995.tb02144.x
Odibo, 2015, Early prediction and aspirin for prevention of pre-eclampsia (EPAPP) study: a randomized controlled trial, Ultrasound Obstet Gynecol, 46, 414, 10.1002/uog.14889
Omrani, 1992, Prevention of pregnancy-induced hypertension by low dose aspirin, Iran J Med Sci, 17, 131
Porreco, 1993, Low-dose aspirin and hypertension in pregnancy, Lancet, 341, 312, 10.1016/0140-6736(93)92672-G
Rotchell, 1998, Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomized trial for the prevention of pre-eclampsia and its complications, Br J Obstet Gynaecol, 105, 286, 10.1111/j.1471-0528.1998.tb10088.x
Schiff, 1989, The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies, N Engl J Med, 321, 351, 10.1056/NEJM198908103210603
Schrocksnadel, 1992, Low-dose aspirin in primigravidae with positive rollover test, Gynecol Obstet Invest, 34, 146, 10.1159/000292748
Sibai, 1993, Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units, N Engl J Med, 329, 1213, 10.1056/NEJM199310213291701
Talari, 2014, Aspirin and preeclampsia prevention in patients with abnormal uterine artery blood flow, Iran Red Crescent Med J, 16, e17175, 10.5812/ircmj.7400
Trudinger, 1988, Low-dose aspirin therapy improves fetal weight in umbilical placental insufficiency, Am J Obstet Gynecol, 159, 681, 10.1016/S0002-9378(88)80034-6
Tulppala, 1997, Low-dose aspirin in prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production, Hum Reprod, 12, 1567, 10.1093/humrep/12.7.1567
Villa, 2013, Aspirin in the prevention of pre-eclampsia in high-risk women: a randomized placebo-controlled PREDO trial and a meta-analysis of randomized trials, BJOG, 120, 64, 10.1111/j.1471-0528.2012.03493.x
Wallenburg, 1991, Effect of low-dose aspirin on vascular refractoriness in angiotensin-sensitive primigravid women, Am J Obstet Gynecol, 164, 1169, 10.1016/0002-9378(91)90678-K
Wallenburg, 1986, Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae, Lancet, 1, 1, 10.1016/S0140-6736(86)91891-X
Wang, 1996, A prospective randomized placebo-controlled trial of low-dose aspirin for prevention of intra-uterine growth retardation, Chin Med J (Engl), 109, 238
Yu, 2003, Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation, Ultrasound Obstet Gynecol, 22, 233, 10.1002/uog.218
Zhao, 2012, Low-dose aspirin prescribed at bed time for the prevention of pre-eclampsia in high-risk pregnant women, Reprod Contracept, 32, 355
Zimmermann, 1997, Effect of low dose aspirin treatment on vascular resistance in the uterine, uteroplacental, renal and umbilical arteries–a prospective longitudinal study on a high risk population with persistent notch in the uterine arteries, Eur J Ultrasound, 5, 17, 10.1016/S0929-8266(96)00203-0
Sterne, 2001, Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis, BMJ, 323, 101, 10.1136/bmj.323.7304.101
Fisher, 2015, Why is placentation abnormal in preeclampsia?, Am J Obstet Gynecol, 213, S115, 10.1016/j.ajog.2015.08.042
Ogge, 2011, Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia, J Perinat Med, 39, 641, 10.1515/jpm.2011.098
Pijnenborg, 1980, Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy, Placenta, 1, 3, 10.1016/S0143-4004(80)80012-9
De Wolf, 1980, The human placental bed: electron microscopic study of trophoblastic invasion of spiral arteries, Am J Obstet Gynecol, 137, 58, 10.1016/0002-9378(80)90387-7
Brosens, 2011, The “Great Obstetrical Syndromes” are associated with disorders of deep placentation, Am J Obstet Gynecol, 204, 193, 10.1016/j.ajog.2010.08.009
Redman, 2015, Preeclampsia, biomarkers, syncytiotrophoblast stress, and placental capacity, Am J Obstet Gynecol, 213, S9.e1, 10.1016/j.ajog.2015.08.003
Soto, 2012, Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion, J Matern Fetal Neonatal Med, 25, 498, 10.3109/14767058.2011.591461
Demers, 2014, Prediction of recurrent preeclampsia using first-trimester uterine artery Doppler, Am J Perinatol, 31, 99, 10.1055/s-0033-1338172
Effendi, 2014, Association between first-trimester placental volume and birth weight, Placenta, 35, 99, 10.1016/j.placenta.2013.11.015
Forest, 2014, Soluble Fms-like tyrosine kinase-1 to placental growth factor ratio in mid-pregnancy as a predictor of preterm preeclampsia in asymptomatic pregnant women, Clin Chem Lab Med, 52, 1169, 10.1515/cclm-2013-0955
Demers, 2015, First-trimester placental and myometrial blood perfusion measured by three-dimensional power Doppler in preeclampsia, Am J Perinatol, 32, 920, 10.1055/s-0034-1396686
Tancrede, 2015, Mid-trimester maternal serum AFP and hCG as markers of preterm and term adverse pregnancy outcomes, J Obstet Gynaecol Can, 37, 111, 10.1016/S1701-2163(15)30331-5
Lesmes, 2015, Prediction of small-for-gestational-age neonates: screening by uterine artery Doppler and mean arterial pressure at 19-24 weeks, Ultrasound Obstet Gynecol, 46, 332, 10.1002/uog.14855
Poon, 2015, Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 19-24 weeks, Ultrasound Obstet Gynecol, 46, 437, 10.1002/uog.14904
Cohen, 2015, The association between maternal antioxidant levels in midpregnancy and preeclampsia, Am J Obstet Gynecol, 213, 695.e1, 10.1016/j.ajog.2015.07.027
Bahado-Singh, 2015, Validation of metabolomic models for prediction of early-onset preeclampsia, Am J Obstet Gynecol, 213, 530.e1, 10.1016/j.ajog.2015.06.044
Wright, 2015, Competing risks model in screening for preeclampsia by maternal characteristics and medical history, Am J Obstet Gynecol, 213, 62.e1, 10.1016/j.ajog.2015.02.018
van Oostwaard, 2015, Recurrence of hypertensive disorders of pregnancy: an individual patient data metaanalysis, Am J Obstet Gynecol, 212, 624.e1, 10.1016/j.ajog.2015.01.009
Achkar, 2015, Vitamin D status in early pregnancy and risk of preeclampsia, Am J Obstet Gynecol, 212, 511.e1, 10.1016/j.ajog.2014.11.009
Sween, 2015, Early-pregnancy percent body fat in relation to preeclampsia risk in obese women, Am J Obstet Gynecol, 212, 84.e1, 10.1016/j.ajog.2014.07.055
Metz, 2014, Preeclampsia in high risk women is characterized by risk group-specific abnormalities in serum biomarkers, Am J Obstet Gynecol, 211, 512.e1, 10.1016/j.ajog.2014.04.027
Baschat, 2014, Prediction of preeclampsia utilizing the first trimester screening examination, Am J Obstet Gynecol, 211, 514.e1, 10.1016/j.ajog.2014.04.018
Schneuer, 2014, Angiopoietin 1 and 2 serum concentrations in first trimester of pregnancy as biomarkers of adverse pregnancy outcomes, Am J Obstet Gynecol, 210, 345.e1, 10.1016/j.ajog.2013.11.012
Bigelow, 2014, Risk factors for new-onset late postpartum preeclampsia in women without a history of preeclampsia, Am J Obstet Gynecol, 210, 338.e1, 10.1016/j.ajog.2013.11.004
Tache, 2014, Population-based biomarker screening and the development of severe preeclampsia in California, Am J Obstet Gynecol, 211, 377.e1, 10.1016/j.ajog.2014.03.026
O'Gorman, 2016, Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation, Am J Obstet Gynecol, 214, 103.e1, 10.1016/j.ajog.2015.08.034
Wright, 2012, A competing risks model in early screening for preeclampsia, Fetal Diagn Ther, 32, 171, 10.1159/000338470
Poon, 2013, Combined screening for preeclampsia and small for gestational age at 11-13 weeks, Fetal Diagn Ther, 33, 16, 10.1159/000341712
O'Gorman, 2016, Study protocol for the randomized controlled trial: combined multimarker screening and randomized patient treatment with ASpirin for evidence-based PREeclampsia prevention (ASPRE), BMJ Open, 6, e011801, 10.1136/bmjopen-2016-011801
Roberge, 2012, Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis, Am J Perinatol, 29, 551
Roberge, 2012, Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis, Fetal Diagn Ther, 31, 141, 10.1159/000336662
Duley, 2007, Antiplatelet agents for preventing pre-eclampsia and its complications, Cochrane Database Syst Rev, 2, CD004659
Leitich, 1997, A meta-analysis of low dose aspirin for the prevention of intrauterine growth retardation, Br J Obstet Gynaecol, 104, 450, 10.1111/j.1471-0528.1997.tb11497.x
Rothwell, 2005, Treating individuals 2. Subgroup analysis in randomized controlled trials: importance, indications, and interpretation, Lancet, 365, 176, 10.1016/S0140-6736(05)17709-5